%PDF-1.4
%
85 0 obj
<>
endobj
82 0 obj
<>
endobj
144 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2005-05-10T18:41:51Z
2024-03-28T21:43:13-07:00
QuarkXPressª: AdobePS 8.8.0 (301)
2024-03-28T21:43:13-07:00
application/pdf
Heather
2004-363.june
uuid:676991bb-1dd2-11b2-0a00-e909277d8900
uuid:676991bd-1dd2-11b2-0a00-d30000000000
endstream
endobj
71 0 obj
<>
endobj
72 0 obj
<>
endobj
86 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 49 0 R/Type/Page>>
endobj
1 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 51 0 R/Type/Page>>
endobj
4 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 53 0 R/Type/Page>>
endobj
15 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 55 0 R/Type/Page>>
endobj
26 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 57 0 R/Type/Page>>
endobj
29 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 59 0 R/Type/Page>>
endobj
32 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 61 0 R/Type/Page>>
endobj
35 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 63 0 R/Type/Page>>
endobj
38 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 65 0 R/Type/Page>>
endobj
178 0 obj
[182 0 R]
endobj
179 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
13.5 787.5 585 -783 re
W n
q
0 792.03 612 -792 re
W n
BT
0 0 0 1 k
/GS1 gs
/T1_0 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 73.868 737.0293 Tm
[(Hutchinson IV)128.8 (. )54.8 (An investigation of polymorphism in the )]TJ
0 -1.25 TD
[(interleukin-10 gene promoter)54.8 (. Eur J Immunogenetics 1997;24:1-8.)]TJ
-2.175 -1.25 Td
[(41.)-875.1 (Crawley E, Kay R, Sillibourne J, Patel P)110.7 (, Hutchinson I, )17.7 (W)79.9 (oo P)110.8 (.)]TJ
2.175 -1.25 Td
[(Polymorphic haplotypes of the interleukin-10 5\325)-201.1 (flanking region)]TJ
T*
(determine variable interleukin-10 transcription and are associated)Tj
T*
[(with particular phenotypes of juvenile rheumatoid arthritis. )54.8 (Arthritis)]TJ
0 Tc T*
[(Rheum 1999;42:1)36.9 (101-8.)]TJ
-0.00011 Tc -2.175 -1.25 Td
[(42.)-875.1 (Fishman D, Faulds G, Jef)17.7 (fery R, et al. )17.7 (The ef)17.7 (fect of novel )]TJ
2.175 -1.25 Td
(polymorphisms in the interleukin-6 \(IL-6\) gene on IL-6 )Tj
T*
(transcription and plasma IL-6 levels and an association with )Tj
T*
(systemic-onset juvenile chronic arthritis. J Clin Invest)Tj
0 Tc 0 Tw T*
(1998;102:1369-76.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(43.)-875.1 (Hajeer )54.8 (AH, Lazarus M, )17.7 (T)35 (urner D, et al. IL-10 gene promoter )]TJ
2.175 -1.25 Td
(polymorphisms in rheumatoid arthritis. Scand J Rheumatol)Tj
0 Tc 0 Tw T*
(1998;27:142-5.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(44.)-875.1 (Lard LR, van Gaalen F)73.9 (A, Schonkeren JJM, et al. )54.8 (Association of the)]TJ
2.175 -1.25 Td
(\3202849 interleukin-10 promoter polymorphism with autoantibody)Tj
T*
[(production and joint destruction in rheumatoid arthritis. )54.8 (Arthritis)]TJ
0 Tc T*
(Rheum 2003;48:1841-8.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(45.)-875.1 (Huizinga )17.7 (TWJ, Keijers )17.7 (V)128.9 (,)-0.1 ( )36.8 (Y)99.8 (anni G, et al. )54.8 (Are dif)17.7 (ferences in )]TJ
2.175 -1.25 Td
(interleukin 10 production associated with joint damage?)Tj
T*
[(Rheumatology Oxford 2000;39:1)36.8 (180-8.)]TJ
-2.175 -1.25 Td
[(46.)-875.1 (Eksdale J, Gallagher G, )17.7 (V)110.8 (erweij CL, Keijsers )17.7 (V)128.9 (,)-0.1 ( )17.7 (W)79.9 (estendorp RGJ,)]TJ
2.175 -1.25 Td
[(Huizinga )17.7 (TWJ. Interleukin 10 secretion in relation to human IL-10)]TJ
T*
[(locus haplotypes. Proc Natl )54.8 (Acad Sci USA)-220.2 (1998;95:9465-70.)]TJ
-2.175 -1.25 Td
[(47.)-875.1 (National Center for Biotechnology Information \(NCBI\). Single)]TJ
2.175 -1.25 Td
[(Nucleotide Polymorphism Database, dbSNP)110.7 (. Bethesda, MD: NCBI;)]TJ
T*
[(Last update date June 9, 2004. )54.8 (Access date December 14, 2004.)]TJ
T*
[(A)74 (vailable from:)]TJ
0 Tw T*
[(http://www)64.8 (.ncbi.nlm.nih.gov/entrez/query)64.8 (.fcgi?db=snp)]TJ
0.02499 Tw -2.175 -1.25 Td
[(48.)-875.1 (Grif)17.7 (fiths )54.8 (AJ, Miller JH, Suzuki DI, Lewontin RC, Gelbart )17.7 (WM. )54.8 (An)]TJ
2.175 -1.25 Td
[(introduction to genetic analysis. 7th ed. New )36.8 (Y)99.8 (ork: )17.7 (W)91.9 (.H. Freeman)]TJ
T*
[(and Company; 1999: Box 24-1 \(electronic version\). )54.8 (Access date)]TJ
T*
(December 6, 2004.)Tj
30.825 41.25 Td
[(49.)-875.1 (Bias )17.7 (WB, Hsu SH, Pollard MK, et al. HLA-DR characterization of)]TJ
2.175 -1.25 Td
(a Chippewa Indian subpopulation with high prevalence of )Tj
T*
(rheumatoid arthritis. Human Immunol 1981;2:155-63.)Tj
-2.175 -1.25 Td
[(50.)-875.1 (T)69.9 (emplin DW)91.7 (, Boyer GS, Lanier )54.8 (AP)110.8 (, et al. Rheumatoid arthritis in)]TJ
2.175 -1.25 Td
[(Tlingit Indians: Clinical characterisation and HLA)-220.2 (associations.)]TJ
0.275 -1.25 Td
(J Rheumatol 1994;21:1238-44. )Tj
-2.45 -1.25 Td
[(51.)-875.1 (Nelson JL, Boyer G, )17.7 (T)69.9 (emplin D, et al. HLA)-220.2 (antigens in )17.7 (Tlingit)]TJ
2.175 -1.25 Td
[(Indians with rheumatoid arthritis. )17.7 (T)35 (issue )54.8 (Antigens 1992;40:57-63.)]TJ
-2.175 -1.25 Td
[(52.)-875.1 (W)39.8 (illiams RC, Jacobsson L)91.7 (TH, Knowler )17.7 (WC, et al. Meta-analysis)]TJ
2.175 -1.25 Td
(reveals association between most common Class II haplotype in)Tj
T*
[(full-heritage native )54.8 (Americans and rheumatoid arthritis. Human)]TJ
T*
(Immunol 1995;42:90-4.)Tj
-2.175 -1.25 Td
[(53.)-875.1 (Radstake )17.7 (TRDJ, Barrera P)110.7 (,)-0.1 ( )54.8 (Albers MJC, Swinkels HL, van de Putte)]TJ
2.175 -1.25 Td
(LBA, van Riel PLCM. Genetic anticipation in rheumatoid arthritis)Tj
T*
(in Europe. J Rheumatol 2001;28:962-7.)Tj
-2.175 -1.25 Td
[(54.)-875.1 (McDermott E, Khan MA, Deighton C. Further evidence for genetic)]TJ
2.175 -1.25 Td
[(anticipation in familial rheumatoid arthritis. )54.8 (Ann Rheum Dis)]TJ
0 Tc 0 Tw T*
(1996;55:475-7.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(55.)-875.1 (W)79.9 (arle MC, Farhan )54.8 (A, Metselaar HJ, et al. )54.8 (Are cytokine gene )]TJ
2.175 -1.25 Td
(polymorphisms related to in vitro cytokine production profiles?)Tj
0.00729 Tw T*
[(Liver T)35 (ranspl )-17.7 (2003;9:170-81.)]TJ
0.02499 Tw -2.175 -1.25 Td
[(56.)-875.1 (Gibson )54.8 (A)79.8 (W)91.8 (, Edber)17.7 (g JC, )17.7 (W)39.9 (u)-0.1 ( J, )17.7 (W)79.9 (estendorp RGJ, Huizinga )17.7 (T)-239.3 (WJ,)]TJ
2.175 -1.25 Td
[(Kimberly RP)110.7 (. Novel single nucleotide polymorphisms in the distal)]TJ
T*
[(IL-10 promoter af)17.7 (fect IL-10 production and enhance the risk of )]TJ
T*
(systemic lupus erythematosus. J Immunol 2001;166:3915-22.)Tj
-2.175 -1.25 Td
[(57.)-875.1 (Barrera P)110.7 (, Faure S, Prud\325homme JF)79.7 (, et al. European genetic study)]TJ
2.175 -1.25 Td
(on rheumatoid arthritis: Is there a linkage of the interleukin-1 )Tj
T*
(\(IL-1\), IL-10 or IL-4 genes to RA? Clin Exp Rheumatol)Tj
0 Tc 0 Tw T*
(2001;19:709-14.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(58.)-875.1 (Eksdale J, McNicholl J, )17.7 (W)79.9 (ordsworth P)110.8 (, et al. Interleukin-10)]TJ
2.175 -1.25 Td
(microsatellite polymorphisms and IL-10 locus alleles in rheumatoid)Tj
T*
[(arthritis susceptibility)64.8 (. Lancet 1998;352:1282-3.)]TJ
ET
0 0 0 1 K
53.468 76.5 m
558.468 76.5 l
S
0 0 0 0 k
494.29 69.365 64.178 -15.665 re
f*
BT
0 0 0 1 k
/T1_1 1 Tf
0 Tc 0 Tw 8 0 0 8 545.468 56.4344 Tm
(991)Tj
ET
0 0 0 0 k
/GS0 gs
104.631 81.583 407.5 -10.833 re
f*
0.5 w
/GS1 gs
104.631 81.583 407.5 -10.833 re
S
BT
0 0 0 1 k
/T1_1 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 54.532 56.7502 Tm
[(Oen, et al: Familial Ser)36.8 (opositive RA)]TJ
ET
Q
Q
q
0 0 612 792 re
W n
BT
0 g
/GS2 gs
/T1_2 8 Tf
108.828 74 Td
(Personal non-commercial use only. The Journal of Rheumatology Copyright\
\251 2005. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_3 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 28, 2024 from )Tj
ET
endstream
endobj
65 0 obj
<>stream
8;Z\7rI2UK#ikkjOOr/U8I-]AS_F%I&Q`%)iPV79#I]DPq$.3qp*X'o:0WD0-Z$"&`#R5S=;V>AJ2AcG;MVQso?)/%B+_P;Q;Vl/F@,2ZMtB`Qg\uQ6%FgZTj4^MJ9D>j;
:rYY6ST^`lK>CqL(^pV$_;Kg[T"m8+Zcc^pbDe1Tq2_9G%5les@fY8-,-(~>
endstream
endobj
69 0 obj
[/Indexed/DeviceRGB 255 68 0 R]
endobj
68 0 obj
<>stream
J,g]g+e/h_!_gCtO=0f)$P%cIi8Zdfc5&3j_8$7g.@L`YKUJNGBP\poR=_;Dl'P(T
(7Boo^^S:71(MN]ZQX/+Cbu.lK"p74pe1T%s.DY%&\1TdJhr54.M9au6>79n6`Q:4
PbLSZTLEE(8E@'*1mg_*eTnN*;*'V3+gm-EEetX%;Bo$ur2ss*N`.-!.kG_q6GDD'
dKoL!8Ka#EV,@V!\j8ZFbp6EE<9cn=N6j0nf;(&;QU6bUD')c@\
9-d\DA=cZ0Q>gIM$$;cd2O@&a;X,Nn_aP(]I1aRc(K1^ue>
gF/(+GaKo$qneLWDrQ#;5\S(\$q'4Q,85`-8;S(=Z"WSBOV*FM)4,?B],R
endstream
endobj
100 0 obj
<>
endobj
88 0 obj
<>
endobj
125 0 obj
<>
endobj
149 0 obj
<>
endobj
89 0 obj
<>
endobj
115 0 obj
<>stream
H|UkPWa 6n#PjE|Q@'
0(00 sF"+fkirmI֭:u{ιD"s)*te:aʿW`a3bŚy-ފgrK/idKF. .IkZZ{}fԻvs >Esl
5*nC>]V&htZNJq\T=ҫtCƜZ)t2Q4IZu&=KC8ej|S8x:QԩU`7c"a`R+ldtVHV `X7
^DbEDVj+^G`a]f}a"xK*
i
eSc4wL{![ vpwsqINGN~28}t#uƜ˜lufv N|(d205dP;=60D_НQ*KL25y'<23#NXp0=